Song, Xiaoling. “Targeting of Both PI3K Akt MTOR Pathway and Mutant EGFR to Overcome Resistance to Tyrosine Kinase Inhibitors in Mutant EGFR-Mediated Lung Cancer”. Onco Reviews 1, no. 1 (November 1, 2013): pp.13–19. Accessed October 31, 2026. https://vripress.com/OR/article/view/81.